BRPI0601290A - composição para prevenção e tratamento de distúrbios cardiovasculares - Google Patents
composição para prevenção e tratamento de distúrbios cardiovascularesInfo
- Publication number
- BRPI0601290A BRPI0601290A BRPI0601290-6A BRPI0601290A BRPI0601290A BR PI0601290 A BRPI0601290 A BR PI0601290A BR PI0601290 A BRPI0601290 A BR PI0601290A BR PI0601290 A BRPI0601290 A BR PI0601290A
- Authority
- BR
- Brazil
- Prior art keywords
- chromium
- prevention
- iii
- treatment
- composition
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 4
- 230000002265 prevention Effects 0.000 title abstract 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 5
- 229910052804 chromium Inorganic materials 0.000 abstract 5
- 239000011651 chromium Substances 0.000 abstract 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 150000001845 chromium compounds Chemical class 0.000 abstract 2
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 abstract 1
- 102000010445 Lactoferrin Human genes 0.000 abstract 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229940046374 chromium picolinate Drugs 0.000 abstract 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical class [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 abstract 1
- UABXPZUCXZAIKN-UHFFFAOYSA-H chromium(3+) pyridine-3-carboxylate Chemical compound C(C1=CN=CC=C1)(=O)[O-].[Cr+3].[Cr+3].C(C1=CN=CC=C1)(=O)[O-].C(C1=CN=CC=C1)(=O)[O-].C(C1=CN=CC=C1)(=O)[O-].C(C1=CN=CC=C1)(=O)[O-].C(C1=CN=CC=C1)(=O)[O-] UABXPZUCXZAIKN-UHFFFAOYSA-H 0.000 abstract 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 abstract 1
- LJAOOBNHPFKCDR-UHFFFAOYSA-K chromium(3+) trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Cr+3] LJAOOBNHPFKCDR-UHFFFAOYSA-K 0.000 abstract 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 abstract 1
- 235000007831 chromium(III) chloride Nutrition 0.000 abstract 1
- 239000011636 chromium(III) chloride Substances 0.000 abstract 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 abstract 1
- 229910000356 chromium(III) sulfate Inorganic materials 0.000 abstract 1
- 235000015217 chromium(III) sulphate Nutrition 0.000 abstract 1
- 239000011696 chromium(III) sulphate Substances 0.000 abstract 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 abstract 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
- 229940078795 lactoferrin Drugs 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyridine Compounds (AREA)
Abstract
"COMPOSIçãO PARA PREVENçãO E TRATAMENTO DE DISTúRBIOS CARDIOVASCULARES". é revelada uma composição para prevenção e tratamento de distúrbios cardiovasculares. A composição inclui a lactoferrina e um composto de cromo trivalente. O composto de cromo trivalente da presente invenção é selecionado do grupo consistindo de cloreto de cromo (III) hexaidratado, cloreto de cromo (III) , acetato de cromo (III), sulfato de cromo (III), picolinato de cromo, nicotinato de cromo, ácido amino quelado de cromo, cromo GTF, cromo de levedura, levedura de cromo, sais inorgânicos de cromo (III), sais orgânicos de cromo trivalente e suas combinações, A presente invenção também revela um método para prevenção e tratamento de doença cardiovascular de um receptor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW094122677A TWI276442B (en) | 2005-07-05 | 2005-07-05 | Composition of controlling and preventing heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0601290A true BRPI0601290A (pt) | 2007-03-06 |
Family
ID=36292943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0601290-6A BRPI0601290A (pt) | 2005-07-05 | 2006-04-19 | composição para prevenção e tratamento de distúrbios cardiovasculares |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070010426A1 (pt) |
| JP (1) | JP2007016012A (pt) |
| KR (1) | KR20070005494A (pt) |
| AU (1) | AU2006201157B2 (pt) |
| BR (1) | BRPI0601290A (pt) |
| CH (1) | CH698459B1 (pt) |
| DE (1) | DE102006012263B4 (pt) |
| FR (1) | FR2888750B1 (pt) |
| GB (1) | GB2428007B (pt) |
| IT (1) | ITMI20060882A1 (pt) |
| MY (1) | MY177085A (pt) |
| NL (1) | NL1032065C2 (pt) |
| TW (1) | TWI276442B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI454221B (en) * | 2008-07-14 | 2014-10-01 | Composition and method for inhibiting formation of body fat | |
| US8815310B2 (en) * | 2011-01-10 | 2014-08-26 | Morteza Naghavi | Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health |
| US9319249B2 (en) * | 2014-08-27 | 2016-04-19 | eTopus Technology Inc. | Receiver for high speed communication channel |
| US12219981B1 (en) * | 2024-05-22 | 2025-02-11 | Phoenix Creative Nutraceuticals, LLC | Methods and compositions to assist and support the formation of red blood cells and hemoglobin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3234001A (en) | 1961-11-29 | 1966-02-08 | Pacific Adhesives Company Inc | Pesticidal composition and method |
| US4923855A (en) | 1983-07-08 | 1990-05-08 | The William Seroy Group | Synthetic GTF chromium material and process therefor |
| US6261606B1 (en) * | 1999-09-14 | 2001-07-17 | Natural Compounds, Ltd. | Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| TW490305B (en) * | 1999-11-25 | 2002-06-11 | Ling-Huei Cheng | Trivalent chromium complex compound for controlling diabetes |
| TW471951B (en) | 2000-04-11 | 2002-01-11 | Ling-Huei Cheng | Thivalent chromium milk product and method for producing the same |
| CN1114618C (zh) * | 2000-05-19 | 2003-07-16 | 程伶辉 | 三价铬复合物、其乳制品及其制造方法 |
| CN1185258C (zh) | 2000-05-19 | 2005-01-19 | 程伶辉 | 三价铬复合物及其应用 |
| JP3633852B2 (ja) | 2000-06-06 | 2005-03-30 | 伶輝 程 | 三価クロム複合物、その乳製品およびその製造方法 |
| US20030191193A1 (en) * | 2002-04-03 | 2003-10-09 | Jillian Cornish | Lactoferrin |
| AU2003291206A1 (en) * | 2002-12-04 | 2004-06-23 | Agennix Incorporated | Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| TW200605902A (en) * | 2004-08-05 | 2006-02-16 | Maxluck Biotechnology Corp | Composition for lowering blood lipid |
-
2005
- 2005-07-05 TW TW094122677A patent/TWI276442B/zh not_active IP Right Cessation
- 2005-09-06 US US11/218,642 patent/US20070010426A1/en not_active Abandoned
-
2006
- 2006-03-14 MY MYPI20061104A patent/MY177085A/en unknown
- 2006-03-15 DE DE102006012263.1A patent/DE102006012263B4/de not_active Expired - Fee Related
- 2006-03-17 GB GB0605387A patent/GB2428007B/en not_active Expired - Fee Related
- 2006-03-21 AU AU2006201157A patent/AU2006201157B2/en not_active Ceased
- 2006-03-22 JP JP2006078947A patent/JP2007016012A/ja active Pending
- 2006-04-05 CH CH00564/06A patent/CH698459B1/it not_active IP Right Cessation
- 2006-04-19 BR BRPI0601290-6A patent/BRPI0601290A/pt not_active Application Discontinuation
- 2006-05-05 IT IT000882A patent/ITMI20060882A1/it unknown
- 2006-06-14 FR FR0605278A patent/FR2888750B1/fr not_active Expired - Fee Related
- 2006-06-27 NL NL1032065A patent/NL1032065C2/nl not_active IP Right Cessation
- 2006-07-03 KR KR1020060062113A patent/KR20070005494A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2888750B1 (fr) | 2011-03-04 |
| KR20070005494A (ko) | 2007-01-10 |
| DE102006012263A1 (de) | 2007-01-18 |
| FR2888750A1 (fr) | 2007-01-26 |
| NL1032065A1 (nl) | 2007-01-08 |
| GB2428007A (en) | 2007-01-17 |
| DE102006012263B4 (de) | 2020-06-18 |
| MY177085A (en) | 2020-09-04 |
| CH698459B1 (it) | 2009-08-14 |
| NL1032065C2 (nl) | 2007-03-09 |
| TW200701987A (en) | 2007-01-16 |
| GB2428007B (en) | 2010-06-02 |
| AU2006201157B2 (en) | 2007-12-13 |
| US20070010426A1 (en) | 2007-01-11 |
| TWI276442B (en) | 2007-03-21 |
| AU2006201157A1 (en) | 2007-01-25 |
| ITMI20060882A1 (it) | 2007-01-06 |
| GB0605387D0 (en) | 2006-04-26 |
| JP2007016012A (ja) | 2007-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4335510A3 (en) | Method for inhibiting bone resorption | |
| WO2008058269A3 (en) | Compounds and methods for modulating protein trafficking | |
| WO2007089548A3 (en) | Compounds and methods for modulating protein trafficking | |
| DE602008006095D1 (de) | Neue salze von bazedoxifen | |
| WO2008070344A3 (en) | Compositions and methods for binding sphingosine-1-phosphate | |
| ATE540941T1 (de) | 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperaz n als verbindung mit kombinierter serotoninwiederaufnahme-, 5-ht3- und 5-ht1a- aktivität zur behandlung kognitiver störungen | |
| WO2006113919A3 (en) | Aryl alkyl acid derivatives for and use thereof | |
| NO20092609L (no) | Tannate salt of rasagiline | |
| WO2005086661A3 (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
| WO2008116219A3 (en) | Uses of monoclonal antibody 8h9 | |
| WO2008062276A8 (en) | Acetylene derivatives as stearoyl coa desaturase inhibitors | |
| NZ598063A (en) | Gram-positive bacteria specific binding compounds | |
| UA99836C2 (en) | Azacytidine analogue and using thereof | |
| DK2144515T3 (da) | Sødemiddelsammensætning med forbedret smag | |
| DE602006009652D1 (de) | Eine herstellungsmethode von entacapon-enthaltenden granulaten für orale dosierformen | |
| DOP2010000391A (es) | Composicion y proceso-356 | |
| WO2005097788A3 (en) | Sulfonamides and uses thereof | |
| BRPI0507903A (pt) | derivados de quinazolina e composição farmacêutica compreendendo os mesmos | |
| BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
| TW200621690A (en) | Novel compounds | |
| WO2007052023A3 (en) | Novel compounds | |
| WO2008112290A3 (en) | Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer | |
| WO2008011113A3 (en) | Thiadiazolidinone derivatives | |
| BRPI0601290A (pt) | composição para prevenção e tratamento de distúrbios cardiovasculares | |
| WO2008067559A3 (en) | Methods for treating and diagnosing fibrotic and fibroproliferative diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 33/24 (2006.01), A61K 38/40 (2006.01) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |